Delivery Order SPE2DB25D3018-SPE2DB25FUYHF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,663.37 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 15 mg tablets (90-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.86 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (90-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,749.28 to AmerisourceBergen Drug Corp for 500 tablets of Pioglitazone HCL 30 mg, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract was awarded on July 22, 2025, with firm fixed pricing and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 90 units. This contract is a firm fixed-price delivery order with a ceiling value of $4,167.80 and an ultimate completion date of September 2, 2025. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pioglitazone HCL 45 mg tablets in quantities of 500 units, with a ceiling value of $1,010.78. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a $3,498.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Pioglitazone HCL 30 mg tablets. The contract, valued at $1,186.51, has an ultimate completion date of April 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,554 to Amerisourcebergen Drug Corporation for the supply of 500 pioglitazone hydrochloride 30 mg tablets. The order was placed under an existing prime vendor contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania over a three-day period concluding on July 17, 2023. No...
- The Defense Logistics Agency awarded a $1,241.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of pioglitazone hydrochloride 45 mg. The contract has a period of performance from June 27, 2023 through June 28, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals to the Department of Defense, this small order for diabetes medication supports the Defense...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,255.25 Firm Fixed Price Delivery Order contract is for the supply of Pioglitazone HCL 30 mg Tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYHFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,804.19 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle that extends through December 2026. The underlying IDC enables the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, and vaccines—to support military healthcare programs worldwide and serve customers including the Defense Health Agency and U.S. Coast Guard. The Pioglitazone HCL procurement fulfills critical pharmaceutical needs within the federal medical supply chain supporting defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 8/21/25 |